Health Technology Assessment Reports
Electronic versions of publications, in Adobe Acrobat format, are available for downloading free of charge for personal use from the HTA website, HTA website or click on the link below.
Printed copies of HTA monographs cost £20 each (post and packing free in the UK) to both public and private sector purchasers from the HTA Despatch Agents, York Publishing Services. Contact details are as follows:
York Publishing Services, PO Box 642, York Y031 7WX, UK.
Tel: +44 (0)870 1616662. Fax: +44 (0)870 1616663. Email: ncchta@yps-publishing.co.uk
Brazier, J., D. Rowen, I. Mavranezouli, A. Tsuchiya, T. Young, Y. Yang, M. Bakhram, and R. Ibbostson. 2012. “Developing and testing methods for deriving preference-based measures of health from condition specific measures (and other patient based measures of outcome).” Health Technology Assessment 16(32): 1-114. Download publication
Claxton, K., S. Palmer, L. Longworth, L. Bojke, S. Griffin, C. McKenna, M. Soares, E. Spackman, and J. H. Youn. 2012. “Informing a decision framework for when NICE should recommend the use of health technologies only in the context of an appropriately designed programme of evidence development.” Health Technology Assessment 16(46). Download publication
Sharples, L. D., C. Jackson, E. Wheaton, G. Griffith, J. T. Annema, C. Dooms, K. G. Tournoy, E. Deschepper, V. Hughes, L. Magee, M. Buxton, and R. C. Rintoul. 2012. “Clinical effectiveness and cost-effectiveness of endobronchial and endoscopic ultrasound relative to surgical staging in potentially resectable lung cancer: Results from the ASTER randomised controlled trial.” Health Technology Assessment 16(18): 1-81. Download publication
Pavey, T. G., N. Anokye, A. H. Taylor, P. Trueman, T. Moxham, K. R. Fox, M. Hillsdon, C. Green, J. L. Campbell, C. Foster, N. Mutrie, J. Searle, and R. S. Taylor. 2011. “The clinical effectiveness and cost-effectiveness of exercise referral schemes: a systematic review and economic evaluation.” Health Technology Assessment 15(44): 1-+. Download publication
Kitchener HC, Almonte M, Gilham C, Dowie R, Stoykova B, Sargent A, Roberts C, Desai M and Peto J on behalf of the ARTISTIC Trial Study Group. ARTISTIC: a randomised trial of human papillomavirus (HPV) testing in primary cervical screening, Health Technol Assess 2009;13(51) Download publication
Hanney S, Buxton M, Green C, Coulson D, Raftery J. An assessment of the impact of the NHS Health Technology Assessment Programme. Health Technol Assess 2007;11(53) http://www.ncchta.org/project/1440.asp
Sharples L, Hughes V, Crean A, Dyer M, Buxton M, Goldsmith K and Stone D. Cost-effectiveness of functional cardiac testing in the diagnosis and management of coronary artery disease: a randomised controlled trial. The CECaT trial. Health Technol Assess 2007;11(49) http://www.ncchta.org/project/1217.asp
Sharples L, Buxton M, Caine N, Cafferty F, Demiris N, Dyer M, Freeman C (2006) Evaluation of the ventricular assist device programme in the UK, Health Technol Assess 2006;10(48) http://www.ncchta.org/project/1256.asp
Buxton M, Caine N, Chase D, et al. A review of the evidence on the effects and costs of Implantable Cardioverter Defibrillator (ICD) therapy in different patient groups, and modelling of cost-effectiveness and cost-utility for these groups in a UK context, Health Technol Assess 2006;10(27) http://www.ncchta.org/project/1208.asp
Peveler R, Kendrick A, Buxton M, et al.Randomised controlled trial to compare the cost effectiveness of tricyclic antidepressants, selective serotonin reuptake inhibitors and lofepramine, Health Technol Assess 2005;9(16) http://www.ncchta.org/project/1101.asp
Townsend J, Buxton M, Harper G. Prioritisation of health technology assessment. The PATHS model: methods and case studies, Health Technol Assess 2003;7(20) http://www.ncchta.org/project/971.asp
Kennedy ADM, Sculpher MJ, Coulter A, Dwyer N, Rees M, Horsley S, et al. A multicentre randomised controlled trial assessing the costs and benefits of using structured information and analysis of women's preferences in the management of menorrhagia, Health Technol Assess 2003;7(8) http://www.ncchta.org/project/898.asp
Bryan S, Weatherburn G, Bungay H, et al. The cost-effectiveness of magnetic resonance imaging for investigation of the knee joint, Health Technol Assess 2001;5(27) http://www.ncchta.org/project/909.asp
Robert G, Milne R. Positron emission tomography: establishing priorities for health technology assessment, Health Technol Assess, 1999;3(16) http://www.ncchta.org/project/1026.asp
Robert G, Stevens A, Gabbay J. 'Early warning systems' for identifying new health care technologies,Health Technol Assess, 1999;3(13) http://www.ncchta.org/project/961.asp
Zeuner D, Ades AE, Karnon J, Brown J, Dezateux C, Anionwu EN. Antenatal and neonatal haemoglobinopathy screening in the UK: review and economic analysis, Health Technol Assess, 1999;3(11) http://www.ncchta.org/project/915.asp
Johnston K, Buxton M, Jones DR, Fitzpatrick R. Assessing the costs of healthcare technologies in clinical trials, Health Technol Assess 1999;3(6) http://www.ncchta.org/project/935.asp
Fitzpatrick R, Shortall E, Sculpher M, et al. Primary total hip replacement surgery: a structured review of outcomes and modelling of cost-effectiveness associated with different prostheses, Health Technol Assess 1998;2(20) http://www.ncchta.org/project/890.asp
Fitzpatrick R, Davey C, Buxton M, Jones D. Evaluating patient-based outcome measures for use in clinical trials, Health Technol Assess 1998;2(14) http://www.ncchta.org/project/934.asp
Sculpher M, Petticrew M, Kelland J, Elliott RA, Holdright DR, Buxton M.Resource allocation for chronic stable angina: a systematic review of effectiveness, costs and cost-effectiveness of alternative interventions, Health Technol Assess 1998;2(10) http://www.ncchta.org/project/875.asp
Chamberlain J, Melia J, Moss S, Brown J.The diagnosis, management, treatment and costs of prostate cancer in England and Wales, Health Technol Assess 1997;1(3) http://www.ncchta.org/project/902.asp
